zepbound and tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply access for adults living with obesity Zepbound Tirzepatide Injection 15mg 15mg

RhIGF-1 is the recombinant form of insulin-like growth factor-1, and has been researched for its potential in mitigating growth hormone (GH) insensitivity

Your body continues producing glutathione naturally Skin does not suddenly darken or deteriorate Results gradually stabilise based on lifestyle and diet Stopping doesnt reverse results overnight but ongoing oxidative stress can slowly affect skin again if antioxidant support isnt maintained

Medicare Part D coverage for Wegovy (oral and injectable) begins January 2027, with an interim program starting July 2026

What was once a relatively small class of drugs has become one of the most significant drivers of pharmacy spend, transforming diabetes care and offering new treatment options to help address obesity

Our commitment to your well-being is built on a few key pillars: Guidance from Board-Certified Physicians: Your health is always in expert hands

Studies on sperm exposed to St Johns wort in the lab showed significant decreases in motility